BioSpace News Archive

Conformal Medical, Inc. announced the positive one-year results from the company’s CONFORMAL Early Feasibility Study.

Entrinsic Bioscience has published a ground-breaking clinical study demonstrating the potential for next generation sports and rehydration beverages, powered by its new Ultra-Hydrating HeatDefense™ formula which promotes dual action rapid rehydration with new levels of heat protection during sports, physical exertion and high heat stress.

Elpiscience Biopharmaceuticals, Inc. today announced it will have three poster presentations at the SITC 2023 Annual Meeting taking place November 3-5, 2023, in San Diego.

Longeveron Inc. today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points.

ValGenesis, Inc. announced that a Canadian biotechnology company selected ValGenesis VLMS – the industry’s most trusted electronic validation lifecycle management system – to digitize its corporate validation process.

Electromed, Inc. today announced that it will issue its financial results press release for the fiscal 2024 first quarter ended September 30, 2023, on Tuesday, November 7, 2023 after the close of the stock market.

ReAlta Life Sciences, Inc. today announced U.S. Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for a Phase 2 clinical trial of RLS-0071 in patients with acute exacerbations of chronic obstructive pulmonary disease (AE-COPD).

Cascade Prodrug Inc. (Cascade), a private preclinical-stage biotechnology company focused on developing novel small molecule therapeutics targeting hypoxia, today announced a poster presentation highlighting preclinical data for it’s lead candidate CPD100Li at the SITC 2023 Annual Meeting, being held November 3-5 in San Diego, CA.

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a significant breakthrough in the treatment of non-small cell lung cancer (NSCLC) with resistance to certain targeted therapies.

Alveo Technologies, Inc. announced a collaboration with Corteva Agriscience to expand the offering of its novel eco-friendly molecular sensing and disease diagnostics technology to include a first-in-field agricultural disease diagnostic.